Auro Del Giglio

Author PubWeight™ 34.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer-related fatigue: a review. Rev Assoc Med Bras 2011 1.73
2 Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. J Clin Oncol 2012 1.39
3 Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. Diagn Pathol 2012 1.36
4 XM02, the first biosimilar G-CSF, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with small cell or non-small cell lung cancer receiving platinum-based chemotherapy. J Thorac Oncol 2009 1.09
5 Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy. J Altern Complement Med 2011 1.07
6 New photodynamic therapy protocol to treat AIDS-related Kaposi's sarcoma. Photomed Laser Surg 2006 1.03
7 Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. Tumour Biol 2012 0.99
8 A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma. BMC Urol 2010 0.95
9 Her-2/neu expression in prostate adenocarcinoma: a systematic review and meta-analysis. J Urol 2010 0.93
10 Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis. Neoplasia 2007 0.91
11 Tegafur-uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle. Ther Adv Med Oncol 2012 0.91
12 Dynamic sentinel node biopsy for inguinal lymph node staging in patients with penile cancer: a systematic review and cumulative analysis of the literature. Ann Surg Oncol 2011 0.89
13 Management of advanced prostate cancer. Rev Assoc Med Bras 2008 0.87
14 Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer 2010 0.85
15 [Analysis of delays in diagnosis and treatment of breast cancer patients at a public hospital]. Rev Assoc Med Bras 2008 0.85
16 Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors. Sao Paulo Med J 2009 0.83
17 Immunocytochemical detection of epithelial cells in the bone marrow of primary breast cancer patients: a meta-analysis. Breast Cancer Res Treat 2004 0.82
18 Ten years of docetaxel-based therapies in prostate adenocarcinoma: a systematic review and meta-analysis of 2244 patients in 12 randomized clinical trials. Clin Genitourin Cancer 2011 0.81
19 Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue. BJU Int 2013 0.81
20 The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemp Clin Trials 2012 0.81
21 Quality of internet information available to patients on websites in Portuguese. Rev Assoc Med Bras 2012 0.81
22 Interventional procedures for cancer pain management. Einstein (Sao Paulo) 2013 0.80
23 [Incidence of the burnout syndrome among Brazilian cancer physicians]. Rev Assoc Med Bras 2006 0.80
24 Increased serum CA-125 levels in patients with lung cancer post thoracotomy. South Med J 2009 0.80
25 Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial. Am J Clin Oncol 2007 0.79
26 [Evaluation of non-oncologist physician's knowledge and attitude towards cancer screening and preventive actions]. Rev Assoc Med Bras 2004 0.79
27 Whole-pulmonary low-dose radiation therapy in agnogenic myeloid metaplasia with diffuse lung involvement. Am J Hematol 2002 0.78
28 Molecular oncogenesis of prostate adenocarcinoma: role of the human epidermal growth factor receptor 2 (HER-2/neu). Tumori 2011 0.78
29 Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial. Breast Cancer 2011 0.78
30 Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer. Anticancer Drugs 2015 0.77
31 Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer. Lung Cancer 2007 0.77
32 Systemic chemotherapy-induced microsatellite instability in the mononuclear cell fraction of women with breast cancer can be reproduced in vitro and abrogated by amifostine. J Pharm Pharmacol 2010 0.77
33 Experience with the ABC Foundation School of Medicine undergraduate meeting. Rev Assoc Med Bras 2010 0.77
34 Heparan sulfate mediates trastuzumab effect in breast cancer cells. BMC Cancer 2013 0.77
35 Formal statistical testing and inference in randomized phase II trials in medical oncology. Am J Clin Oncol 2013 0.76
36 Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting. Support Care Cancer 2014 0.75
37 Treatment of breast cancer patients from a public healthcare system in a private center: costs of care for a pilot public-private partnership in oncology. Einstein (Sao Paulo) 2013 0.75
38 Treatment of a frail older patient with diffuse large B-cell lymphoma on maintenance dialysis: attenuated immunochemotherapy and adapted care plan. Case Rep Oncol 2013 0.75
39 [The training the physician and the communication of a patient's death to family members]. Rev Assoc Med Bras 2005 0.75
40 Tegafur-uracil (UFT) in lower doses is safe for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle. Ther Adv Med Oncol 2013 0.75
41 Paullinia cupana for control of hot flashes in breast cancer patients: a pilot study. Einstein (Sao Paulo) 2013 0.75
42 Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas. Sao Paulo Med J 2008 0.75
43 Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial. Acta Haematol 2006 0.75
44 Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors. J Altern Complement Med 2014 0.75
45 Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing lymphomas: results of a phase I trial. Acta Haematol 2004 0.75
46 [Professional or household performance of patients with breast cancer undergoing chemotherapy]. Rev Assoc Med Bras 2009 0.75
47 [Prospective evaluation of clinical and Doppler ultrasound characteristics of cancer patients with suspicion of deep venous thrombosis]. Rev Assoc Med Bras 2006 0.75
48 [Absolute number or lymphonodal quotient: which is the best prognostic factor for women with breast neoplasms? ]. Rev Assoc Med Bras 2006 0.75
49 [Metastatic melanoma of the gallbladder mimicking Bladder Calculi]. Rev Assoc Med Bras 2005 0.75
50 [Clinical research conducted by medical students: its potential for learning and the national scientific production]. Rev Assoc Med Bras 2006 0.75
51 [How to consent without understanding?]. Rev Assoc Med Bras 2009 0.75
52 [A new paradigm for the treatment of cancer]. Rev Assoc Med Bras 2004 0.75
53 Does Time-to-Chemotherapy Impact the Outcomes of Resected Ovarian Cancer? Meta-analysis of Randomized and Observational Data. Int J Gynecol Cancer 2017 0.75
54 A medical student-staffed outpatient oncology clinic: a 10-year Brazilian experience. J Cancer Educ 2008 0.75
55 Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial. J Pain Symptom Manage 2012 0.75